Meiji Yasuda Life Insurance Co trimmed its position in shares of Astera Labs, Inc. (NASDAQ:ALAB – Free Report) by 62.1% during the second quarter, HoldingsChannel reports. The fund owned 1,950 shares of the company’s stock after selling 3,200 shares during the quarter. Meiji Yasuda Life Insurance Co’s holdings in Astera Labs were worth $942,000 as of its most recent filing with the Securities & Exchange Commission.
Several other large investors have also recently added to or reduced their stakes in the company. Greenleaf Trust lifted its position in Astera Labs by 1.8% in the second quarter. Greenleaf Trust now owns 2,000 shares of the company’s stock valued at $966,000 after purchasing an additional 36 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in Astera Labs by 31.6% in the 2nd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 854,492 shares of the company’s stock valued at $412,737,000 after purchasing an additional 205,301 shares in the last quarter. Royal London Asset Management Ltd. increased its position in Astera Labs by 8.7% during the 2nd quarter. Royal London Asset Management Ltd. now owns 45,588 shares of the company’s stock worth $22,020,000 after purchasing an additional 3,659 shares during the period. Van ECK Associates Corp increased its position in Astera Labs by 20.0% during the 2nd quarter. Van ECK Associates Corp now owns 2,237,961 shares of the company’s stock worth $1,080,980,000 after purchasing an additional 373,545 shares during the period. Finally, Nissay Asset Management Corp Japan raised its stake in shares of Astera Labs by 79.6% during the 2nd quarter. Nissay Asset Management Corp Japan now owns 105,965 shares of the company’s stock worth $51,183,000 after buying an additional 46,952 shares in the last quarter. 60.47% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling
In other news, General Counsel Philip Mazzara sold 6,801 shares of the firm’s stock in a transaction on Monday, August 17th. The stock was sold at an average price of $340.50, for a total value of $2,315,740.50. Following the completion of the transaction, the general counsel owned 96,542 shares in the company, valued at $32,872,551. This trade represents a 6.58% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, COO Sanjay Gajendra sold 90,630 shares of Astera Labs stock in a transaction on Monday, August 17th. The stock was sold at an average price of $340.35, for a total value of $30,845,920.50. Following the transaction, the chief operating officer directly owned 1,119,038 shares of the company’s stock, valued at $380,864,583.30. This trade represents a 7.49% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 419,244 shares of company stock valued at $163,135,169 in the last three months. 10.40% of the stock is owned by insiders.
Astera Labs Trading Down 4.8%
Astera Labs (NASDAQ:ALAB – Get Free Report) last released its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, beating the consensus estimate of $0.69 by $0.11. The firm had revenue of $392.40 million during the quarter, compared to the consensus estimate of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.Astera Labs’s quarterly revenue was up 104.5% on a year-over-year basis. During the same period last year, the business posted $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Sell-side analysts forecast that Astera Labs, Inc. will post 2.7 earnings per share for the current fiscal year.
Analyst Ratings Changes
ALAB has been the topic of a number of analyst reports. Barclays lifted their price target on Astera Labs from $200.00 to $325.00 and gave the company an “equal weight” rating in a research note on Monday, July 20th. UBS Group reiterated a “neutral” rating and issued a $425.00 price objective on shares of Astera Labs in a research report on Wednesday, August 5th. Needham & Company LLC raised their target price on Astera Labs from $260.00 to $425.00 and gave the company a “buy” rating in a report on Wednesday, August 5th. Morgan Stanley raised their target price on Astera Labs to $335.00 and gave the company an “overweight” rating in a report on Monday, August 3rd. Finally, Stifel Nicolaus boosted their target price on shares of Astera Labs from $260.00 to $460.00 and gave the stock a “buy” rating in a research report on Wednesday, June 24th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and eight have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $340.53.
View Our Latest Research Report on ALAB
About Astera Labs
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
See Also
- Five stocks we like better than Astera Labs
- From SaaS-pocalypse to Perfect Storm: Workday’s AI Growth Story Strengthens
- These 3 GARP Stocks Show Why Growth and Value Do Not Have to Clash
- Venture Into High-Volatility Corners of the Market With These 3 ETFs
- 3 Retail Stocks to Watch After a Big Consumer Earnings Week
Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
